UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacokinetic drug interactions in liver disease: An update

World journal of gastroenterology : WJG, 2016-01, Vol.22 (3), p.1260-1278

2016

Volltextzugriff (PDF)

Differential effect of liver cirrhosis on the pregnane X receptor-mediated induction of CYP3A1 and 3A2 in the rat

Drug metabolism and disposition, 2014-10, Vol.42 (10), p.1617-1626

2014

Volltextzugriff (PDF)

Differential Inducing Effect of Benzo[a]pyrene on Gene Expression and Enzyme Activity of Cytochromes P450 1A1 and 1A2 in Sprague-Dawley and Wistar Rats

DRUG METABOLISM AND PHARMACOKINETICS, 2012, Vol.27 (6), p.640-652

2012

Volltextzugriff (PDF)

Inhibition of Cytochrome P450 2C8-mediated Drug Metabolism by the Flavonoid Diosmetin

DRUG METABOLISM AND PHARMACOKINETICS, 2011-01, Vol.26 (6), p.559-568

2011

Volltextzugriff (PDF)

Expression and distribution of the adrenomedullin system in newborn human thymus

PloS one, 2014-05, Vol.9 (5), p.e97592-e97592

2014

Volltextzugriff (PDF)

Severe liver cirrhosis markedly reduces AhR-mediated induction of cytochrome P450 in rats by decreasing the transcription of target genes

PloS one, 2013-04, Vol.8 (4), p.e61983

2013

Volltextzugriff (PDF)

Flavonoids Diosmetin and Hesperetin are Potent Inhibitors of Cytochrome P450 2C9-mediated Drug Metabolism in vitro

Drug metabolism and pharmacokinetics, 2010-01, Vol.25 (5), p.466-476

2010

Volltextzugriff (PDF)

Diagnostic Value of Plasma Cystatin C as a Glomerular Filtration Marker in Decompensated Liver Cirrhosis

Clinical chemistry (Baltimore, Md.), 2002-06, Vol.48 (6), p.850-858

2002

Volltextzugriff (PDF)

Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase and catalase activities, and protects isolated atria from menadione toxicity

Life sciences (1973), 2003-05, Vol.72 (24), p.2741-2750

2003

Volltextzugriff (PDF)

Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes

Biochemical pharmacology, 2008-03, Vol.75 (6), p.1426-1437

2008

Volltextzugriff (PDF)

Flavonoids Diosmetin and Hesperetin are Potent Inhibitors of Cytochrome P450 2C9-mediated Drug Metabolism in vitro

DRUG METABOLISM AND PHARMACOKINETICS, 2010, Vol.25 (5), p.466-476

2010

Volltextzugriff (PDF)

An intracellular adrenomedullin system reduces IL-6 release via a NF-kB-mediated, cAMP-independent transcriptional mechanism in rat thymic epithelial cells

Cytokine (Philadelphia, Pa.), 2016-12, Vol.88, p.136-143

2016

Volltextzugriff (PDF)

The effect of liver disease on inhibitory and plasma protein-binding displacement interactions: an update

Expert opinion on drug metabolism & toxicology, 2010-10, Vol.6 (10), p.1215-1230

2010

Volltextzugriff (PDF)

Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis

Clinical pharmacology and therapeutics, 2006-12, Vol.80 (6), p.597-606

2006

Volltextzugriff (PDF)

Fluvoxamine pharmacokinetics in healthy elderly subjects and elderly patients with chronic heart failure

British journal of clinical pharmacology, 2010-03, Vol.69 (3), p.279-286

2010

Volltextzugriff (PDF)

Cytochrome P450 1A2 is a Major Determinant of Lidocaine Metabolism in Vivo: Effects of Liver Function

Clinical pharmacology and therapeutics, 2004-01, Vol.75 (1), p.80-88

2004

Volltextzugriff (PDF)

In vitro hepatic conversion of the anticancer agent nemorubicin to its active metabolite PNU-159682 in mice, rats and dogs: A comparison with human liver microsomes

Biochemical pharmacology, 2008-09, Vol.76 (6), p.784-795

2008

Volltextzugriff (PDF)

Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine

Clinical pharmacology and therapeutics, 2006-05, Vol.79 (5), p.489-499

2006

Volltextzugriff (PDF)

Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: Phase I study

Cancer, 2002-01, Vol.94 (2), p.492-499

2002

Volltextzugriff (PDF)

Enzyme inhibition and induction in liver disease

Current clinical pharmacology, 2008-01, Vol.3 (1), p.56-69

2008

Volltextzugriff (PDF)

Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function

British journal of clinical pharmacology, 2003-01, Vol.55 (1), p.86-93

2003

Volltextzugriff (PDF)

Co-administration of sirolimus alters tacrolimus pharmacokinetics in a dose-dependent manner in adult renal transplant recipients

Pharmacological research, 2006-09, Vol.54 (3), p.181-185

2006

Volltextzugriff (PDF)

A Comparison Between Different Methods for the Determination of Reduced and Oxidized Glutathione in Mammalian Tissues

Free radical research, 1997-01, Vol.26 (5), p.449-455

1997

Volltextzugriff (PDF)

Needle and trocar injuries in diagnostic laparoscopy under local anesthesia: what is the true incidence of these complications?

Journal of laparoendoscopic & advanced surgical techniques. Part A, 2003-06, Vol.13 (3), p.181-184

2003

Volltextzugriff (PDF)

Pharmacokinetics of intraperitoneal cisplatin and doxorubicin

Surgical Oncology Clinics of North America, 2003-07, Vol.12 (3), p.781-794

2003

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(70)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacokinetic drug interactions in liver disease: An update

Differential effect of liver cirrhosis on the pregnane X receptor-mediated induction of CYP3A1 and 3A2 in the rat

Differential Inducing Effect of Benzo[a]pyrene on Gene Expression and Enzyme Activity of Cytochromes P450 1A1 and 1A2 in Sprague-Dawley and Wistar Rats

Inhibition of Cytochrome P450 2C8-mediated Drug Metabolism by the Flavonoid Diosmetin

Expression and distribution of the adrenomedullin system in newborn human thymus

Severe liver cirrhosis markedly reduces AhR-mediated induction of cytochrome P450 in rats by decreasing the transcription of target genes

Flavonoids Diosmetin and Hesperetin are Potent Inhibitors of Cytochrome P450 2C9-mediated Drug Metabolism in vitro

Diagnostic Value of Plasma Cystatin C as a Glomerular Filtration Marker in Decompensated Liver Cirrhosis

Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase and catalase activities, and protects isolated atria from menadione toxicity

Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes

Flavonoids Diosmetin and Hesperetin are Potent Inhibitors of Cytochrome P450 2C9-mediated Drug Metabolism in vitro

An intracellular adrenomedullin system reduces IL-6 release via a NF-kB-mediated, cAMP-independent transcriptional mechanism in rat thymic epithelial cells

The effect of liver disease on inhibitory and plasma protein-binding displacement interactions: an update

Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis

Fluvoxamine pharmacokinetics in healthy elderly subjects and elderly patients with chronic heart failure

Cytochrome P450 1A2 is a Major Determinant of Lidocaine Metabolism in Vivo: Effects of Liver Function

In vitro hepatic conversion of the anticancer agent nemorubicin to its active metabolite PNU-159682 in mice, rats and dogs: A comparison with human liver microsomes

Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine

Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: Phase I study

Enzyme inhibition and induction in liver disease

Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function

Co-administration of sirolimus alters tacrolimus pharmacokinetics in a dose-dependent manner in adult renal transplant recipients

A Comparison Between Different Methods for the Determination of Reduced and Oxidized Glutathione in Mammalian Tissues

Needle and trocar injuries in diagnostic laparoscopy under local anesthesia: what is the true incidence of these complications?

Pharmacokinetics of intraperitoneal cisplatin and doxorubicin

Suchergebnisse filtern